Introduction
Gene therapy as a new therapeutic strategy has made great progresses during the past few years. Nevertheless, there are still several critical issues yet to be resolved, one of which is the control of therapeutic transgene expression both temporally and spatially in vivo. Many expression regulation schemes have been proposed. Most extensively studied are vector systems containing promoters that respond to the binding of small molecules such as tetracycline 1 or rapamycin. 2 The transgene expression can thus be controlled through administration of the small molecular drugs. 3, 4 The expressions of therapeutic genes including hGH, GM-CSF were shown to be effectively controlled with such a 'Tet-on' system in vitro. 5 In vivo, Rizzuto et al used a similar vector encoding the erythropoietin gene-transfected mouse muscle by electroporation. Erythropoietin expression was shown to be turned on and kept on with daily oral doxycycline administration for 56 days. 6 Recently Perez et al reported further modifications to the 'Tet-on'system to reduce the usually high background expression (leakiness). The so called 'Tet off' system they reported enabled tighter controlling of transgene IL-10 expression after electrotransfer in mouse mucles, which lasted for 3 months. 7 While the small molecule regulation systems are mainly designed for temporal control of gene expression, there are also occasions that spatial control of gene expression is important. Especially in cancer gene therapy applications where toxic gene products may result in serious side effects if the gene expression occurs not only in tumors but also in normal tissues. Most earlier attempts have been focused on developing tissuespecific promoters (TSPs). 8 Indeed Steiner et al 9 recently successfully demonstrated the potential of a prostatespecific promoter in a canine model. However, a lot of TSP-based systems have not been very satisfactory due to low expression level in targeted tissue and/or high background in nontargeted tissues. A rather different approach is to use external signals to trigger gene expression when and where needed. One successful example is the radio-sensitive EGR1 promoter system. 10 ,11 TNF transgene expression was specifically activated inside a tumor using mild dose of ionizing radiation, which resulted in greatly enhanced tumor killing effect and reduced toxicity. 12 Despite the significant efficacy of the EGR1-TNF system, it has been realized that the induction rate of the EGR1 promoter is still quite low, at about eight fold maximum.
Another physical signaling system that has shown great promise is the heat-shock-related promoter system. 13 Using a recombinant adenoviral vector containing HSP70B, Smith et al reported that luciferase transgene activity increased about 212 folds in transfected cells after heat treatment at 431C for 20-30 min. In animal models, the genes were also shown to be preferentially turned on where local hyperthermia was applied. 14 However, in vivo gene expression controlled by heatshock-related promoter was often found very complex and hard to quantify, due to the microscopic heating environment that resulted from local anatomic structures and microvasculature perfusion patterns. 15 Although for most of the earlier studies in which suicidal or cytotoxic genes were used and the targeted tissue was cancer, the mere magnitude and duration of gene expression were not as crucial. We think it is still important to investigate the optimal conditions to activate transgene expression for the heat-shock promoter system. Another important aspect that we want to address in this paper is the temporal behavior of the transgene expression controlled by heat-shock promoters. Especially for the applications where nontoxic therapeutic genes were to be used, such optimization of transgene expression efficiency, and temporal control profiles, would be essential.
For optimizing gene expression and temporal control of the heat-inducible system, one very important parameter is the heat application method. Although culture cells can be easily heated by water bath, in vivo heating of a specific tissue requires both spatial specificity and instant time response. Among the various techniques available to induce local hyperthermia, focused ultrasound irradiation (FUS) is considered most attractive, thanks to its noninvasiveness. 16 Smith et al in their work used an ultrasound applicator immersing in a waterfilled chamber to heat the abdominal skin of the mouse to turn on transgene expression. However, no temperature parameters were reported. Most recently, Guilhon et al developed a more advanced system using magnetic resonance imaging (MRI)-guided FUS. 17 The built-in MRI imaging system allowed precise targeting of the ultrasound irradiation and accurate temperature control. The system we used in this study is based on a similar ultrasound focusing mechanism but without the MRI imaging guidance. What we have done differently was that we used a thermal coupler for temperature measurement and feedback control of the ultrasound beam intensity. And more significantly, we used a constant temperature heating regimen that would last half an hour to allow heat equilibration in tissue, as compared to the 3 min heat-shock strategy used by Guilhon et al.
In addition, because we were interested in the optimized gene expression efficiency and the complete time response, we chose to examine the i.m. delivered plasmid system because the plasmids were known to remain stable in muscle cells for months. 18 Electroporation was used to further enhance the delivery efficiency.
Results

Heat sensitive plasmid construction
The reporter gene luciferase was cloned at the immediate downstream of the HSP70B promoter on a StressGen HSP70B Inducible Cloning Vector (pD3SX). Two constructs were made. pHLA contained an SV40 enhancer sequence connected to the luciferase coding region. In contrast, pHLB had only the minimum luciferase coding region. CHO cells were transfected with the two plasmid constructs by cationic liposome agents and subjected to the same heat treatment (431C, 1 h.). Luciferase activities were assayed at different time points and shown in Figure 1 . The background gene expression without heat treatment was substantial from the pHLA construct, presumably due to the enhancer sequence. The background from pHLB was merely detectable. After heat treatment, the luciferase activity increased to about sevenfold over background for pHLA and 137-fold over background for pHLB. The time courses of gene activation were also different. Highest luciferase activity was detected at 24 h after heating for pHLA and 8 h after heating for pHLB.
To examine the complete time course of transgene activiation and deactivation, we used a plasmid encoding luciferase gene under the control of an SV40 promoter (pGL3-control) as a control (Figure 2 inset). The luciferase activity resulted from the pGL3-control construct were maintained at a reasonably constant level for 144 h, suggesting that there was limited plasmid degradation or cell death within that time frame. In contrast, luciferase expression from the pHLB construct decreased gradually to close to the background level in 72 h. When the heat treatment was applied again at 72 h after the first heat treatment as shown in Figure 2 , the gene expression was once again turned on, to almost the same level as the first activation. 
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Ultrasound-mediated local hyperthermia
We used a custom-built ultrasound-mediated local hyperthermia system to apply heat treatment to mouse gastrocnemius muscles. A schematic diagram of the instrument setup was depicted in Figure 3a and b showed a typical thermal imaging of a mouse during hyperthermia treatment using a radiometric infrared camera. The thermocouple readings, as well as the infrared image monitoring, were used through out our experiments to ensure reproducible heat treatment in vivo.
Transgene expression activation by in vivo FUS hyperthermia
The transgene expression profile of the pHLB construct in response to heat treatment in vivo was quite different from what it was in cultured cells. We tested the effects of heat treatment at different temperatures from 37 to 431C. Most surprisingly, at 431C where optimal promoter activation was observed in cultured cells, we could not detect any luciferase activity. Visual examination of the mouse legs suggested the existence of excessive hemorrhage and serious damage to the muscle fibers. Further evaluation of the tissue damage using an Evans Blue assay indeed confirmed that there were extensive myofiber disruption and cell membrane permeation after heat treatment at temperature above 411C (Figure 4 ). Such damage apparently impaired much of the gene transcription and translation mechanisms of many muscle cells that almost abolished transgene expression.
It was actually when FUS treatment was carried out at 391C that we observed the optimal gene expression activation. Luciferase expression was turned on quickly after the heat treatment, increasing 10-folds within a day. It then dropped back to background level in 3 days ( Figure 5 , line &), suggesting that HSP70B promoter activation was also temporary in vivo. When the heat treatment was at 411C, the transgene expression was much lower (line K). The luciferase expression after heat treatment at 431C was about and even lower than the background level (data not shown).
In addition, we also show that the gene constructs would be turned on only after and right after the heat treatment. They remained virtually silent inside muscle cells after transfection, and when the heat treatment was applied. 3 days later, the luciferase activity rose to a similar activated level ( Figure 5 , line n).
The effect of repeated heat treatment
Since the activated transgene expression was shown to be temporary and lasted only about 2 days, we tested the effect of subsequently repeated heat treatment. Interestingly, if a second treatment was applied at 391C 3 days after the first heat treatment, much lower luciferase activity was detected compared to what would be expected after the first heat treatment. However, when we raised the heating temperature to 401C, activated luciferase activity would reach the same level as the first activation (Figure 6a ). Furthermore, we varied the time when the second heat treatment was applied. The luciferase activity came out much lower after the second treatment 3 days post the first treatment, but was significantly higher when the second treatment was at 7 days after (Figure 6b ).
Discussion
Control of transgene expression is crucial for gene therapy.
Strategies that promise precise control of transgene expression will undoubtedly play important roles in future developments. The heat sensitive system based on HSPrelated promoters represents a promising possibility. In principle, it would allow both spatial and temporal expression regulation, and the noninvasive nature of the activation mechanism also made it attractive to many potential applications. In addition to suicidal cancer gene therapy applications, it may also be useful for therapeutic gene expression where transgenes products may be needed to be expressed at specific time and specific locations. In those circumstances, optimizations of the activation process and expression duration become essential.
We observed in this study that the transgene expression activation process in vivo is considerably different from that in vitro. For in vitro cell culture systems, it was well documented that hyperthermia of 42-431C is optimal for HSP70-related promotors. However, in vivo when mouse muscles were heated to 431C, detrimental tissue damage was observed. Even heating at 411C Transgene regulation by hyperthermia L Xu et al resulted in substantial tissue damages that interfered with the transgene expression. The transgene expression in vivo was optimal with heating at 391C in our study. This is notably different from what was reported by Guilhon et al. In their study, they compared the effects of 3-min heat shocks at various focal temperatures to implanted tumors in vivo, and reported there was no visible tissue damage from 42 to 501C. The highest transgene expression was observed at 501C, while at 421C almost no expression was found. Although different tissue types were examined in the two studies (tumor versus muscle), the discrepancy is still significant, considering the common view that tumors are usually less tolerant to hyperthermia treatment than normal tissues. We found only a few other papers that compared transgene expressions with different heating parameters in vivo. Vekris et al 19 tried two regimens: 501C for 3 min and 431C for 30 min using a water-filled needle traversed through the tumor. They reported that expression with the first regimen was a little better. Guilhon et al 20 again using the 3 min heat-shock strategy claimed that 401C was the minimum requirement for strong induction. Other studies that applied heat treatment with longer heating durations were reported by Huang et al 21 and Smith et al.
14 However, Huang's study was performed by immersing the tumor-bearing leg in a 42.51C water bath, and Smith's study did not report the in situ tissue temperature during heat treatment. There seems to be substantial differences between the two heat treatment regimens, heat shock versus slow heating, which resulted in the different in vivo heat response and activation profile. We think although the temperature measurement Results are shown as mean7s.e., n ¼ 6. B: luciferase activities without heat treatment; &: luciferase activities after hyperthermia treatments at 391C; K: luciferase activities after hyperthermia treatments at 411C; n: hyperthermia treatment was applied on day three (as indicated by $) at 391C.
Transgene regulation by hyperthermia L Xu et al and control were extremely precise in Guilhon's study using the MRI imaging analysis method, the 501C temperature reported in their study may represent only the temperature at the very focal point of the ultrasound beams. When considering the extensive microvasculature perfusion in vivo, heat generated at the focal point may quickly dissipate through out the surrounding tissues. The overall tissue temperature may be much lower. In addition, the 3 min heating time may also be too short for the tissues to reach heat equilibrium. In comparison, the slower heating and longer duration regimen we used, combined with continuous temperature monitoring and feedback controlling, may allow easier heat equilibrium and more homogenous temperature distribution throughout the tissues. In fact, Vekris et al in their study also observed a shallower temperature gradient and wider spread of transgene expression with the longer duration heating regimen. 19 Concerning the time course of transgene activation in vivo, it is surprising that almost all the studies published examined only the promoter activation (turn on) phase. There are some works in vitro that followed the complete time course of promoter activation and deactivation. However, for in vivo, most of the studies were designed for cytotoxic gene therapy of cancer, in which the later was not important. However, when considering the potential of using the heat-regulated system for therapeutic gene expression, it is extremely important to understand the time course of gene expression, and the possibility of subsequent reactivation.
In our study, we showed that it is possible to use mild heat treatment as an in vivo 'switch' for transgene expression. The gene expression reached peak level on the first day after heat treatment (activated), and dropped back to the background level on the third day (deactivated). The plasmid delivered earlier can serve as a depot which can be activated at a later time when needed. More significantly, we also demonstrated that the same plasmids can be turned on repeatedly under certain circumstances. We found that prior heat treatment history would temporarily weaken the promoter sensitivity to a later heat treatment. This may be attributed to a phenomenon called thermotolerance. 22 It was suggested that heat-shock factors and HSPs produced during a heat treatment would not be cleared quickly after removing of the heating condition. Some of them would remain in the cytosol, and some entered the nuclei, which may interfere with subsequent activation mechanism. 23 Nevertheless, in our experiment, we showed that such a thermotolerance phenomenon would attenuate over time after the heat treatment. When we applied the second activation on the seventh day after the first heating, the thermotolerance effect did not seem to interfere with the transgene activation significantly. And interestingly, we found in another set of experiments that it is also possible to overcome such a thermotolerance effect by simply raising the heat treatment temperature up one degree. To further investigate the long-term thermotolerance effect, we would like to follow the transgene activity after several heat treatments and in a longer time scale. However, the mouse model we used did not allow for too many FUS treatments. For further studies, a bigger animal model would be more appropriate, and secreted reporter gene should be used for easy detection.
Under another consideration, we also examined in this study the effect of vector construction on the gene activation and deactivation process, because background expression level and induction rate are both important parameters of an inducible transgene expression system. We showed that minor sequence components in gene constructs may interfere with the induction efficiency and time course of expression significantly. In addition, the gene delivery method is also important. Studies by Huang et al and Smith et al used adenoviral vectors containing the HSP70 promoter. 21, 14 The expression efficiency was high both in vitro and in vivo, but the transfection was transient and may not be suitable for applications when longer expression duration is needed. On the other hand, intramuscularly delivered DNA plasmids were shown to persist in muscle cells for months. 6, 7 Electroporation can further enhance the delivery efficiency. The bare minimal pHLB construct used in this study allowed us to eliminate most possible interferences and focus on only the effects of different treatment parameters. There is a possibility that the electroporation process may introduce stress that would interfere with the heat activation mechanism. However, since we did not detect any tissue damage after electroporation, and the gene expression before heat Figure 6 Transgene expression after repeated heat treatments. The activation of transgene expression upon reapplied hyperthermia treatment was evaluated. Luciferase activity was assayed on the next day of the marked heat treatment. Results are shown as mean7s.e., n ¼ 6. (a) The first heat treatment was applied on day 1 at 391C and a second heat treatment was applied 3 days after at 39 or 401C, respectively. (b) The first heat treatment was applied on day 1 at 391C and a second heat treatment was applied at 391C 3 or 7 days after, respectively.
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In summary, we examined in this work the detailed transgene activation profile and complete time course of an in vivo heat-inducible transgene expression system. The system allows effective temporal as well as spacial control of transgene expression, and is easy to implement. Further investigations using therapeutic genes to explore possible clinical applications are warranted.
Materials and methods
Plasmid construction
Plasmids pGL3-control and pGL3-basic were both purchased from Promega Corp. (Madison, WI, USA). The luciferase coding region was cut out and cloned into pD3SX (Stressgen Biotechnologies Corp. Canada) to obtain plasmids pHLA and pHLB, respectively. The constructs were confirmed by restriction enzyme digestion. The plasmids were amplified, purified using QIAfilter plasmid Mega kit (Qiagen, Germany), and stored frozen in PBS before use.
Gene expression in cultured cells
Luciferase gene expression from various gene constructs was examined in a cell culture assay. Chinese Hamster Ovary (CHO) cells were from ATCC (VA, USA) and maintained in DMEM (Life Technologies, Inc., USA) containing 10% fetal bovine serum (Hyclone, USA) at 371C. Plasmids were transfected into cells using cationic lipid DOTAP (Avanti Polar lipids, Inc., USA) at 4:1 charge ratio as previously described. 24 At 24 h after transfection, the culture plates were wrapped with parafilm, and floated on water bath in an enclosed chamber for 1 h at 431C. Then they were put back and maintained at 371C. At specific times afterwards, cells were lysed and luciferase activity was examined using a Promega luciferase assay kit (Madison, WI, USA). Luciferase activities were reported as relative light unit detected using Turner Designs Luminometer (Model TD-20/20, Promega, WI, USA). Total protein concentration was also determined using the Bradford assay kit (Amresco, USA).
In vivo gene transfer and transgene expression assay
All the animal experiments were designed and performed abiding by the regulations of SJTU and the Chinese government. Female BALb/c mice were purchased from Fudan University Animal Facility (Shanghai, China). Before experiments, mice were anesthetized using 40 mg/ml Chloral hydrate at 1% volume relative to body mass. After complete sedation, mice were given injections of 40 ml of 125 mg/ml plasmid DNA in PBS per gastrocnemius muscle. Immediately after injection, electroporation was performed using a self-made electropulse generator and a two-needle electrode. We used six 200 V/cm square wave pulses for 50 ms each with 1 s intervals. The mice were later killed and gastrocnemius muscles were collected for examination. To assay for luciferase activity, tissues were homogenized in 1 ml of Promega lysis reagent using a Bead-beater (Cole Parma, USA). The homogenates were then centrifuged at 6000 rpm for 5 min and the supernants were assayed using the Luciferase Assay Kit from Promega.
Ultrasound-mediated hyperthermia treatment
Mice were subjected to ultrasound-mediated hyperthermia treatment 24 h after electroporation gene delivery. The instrument was custom built using parts generously provided by Professor Fucheng Sun at the Department of Biomedical Engineering in Shanghai JiaoTong University. The working frequency of the ultrasound transducer was 1.0 MHz and the diameter of the transducer was 30 mm. The transducer was set up on the top of a columnar housing covered by latex. The columnar housing was filled with circulated degassed water to prevent overheating. Continuous sinusoidal signal was generated by a 5887H signal generator and amplified by a 5887H amplifier (Zhongce Electronics Co. Ltd., Ningbo, China) before feeding to the transducer. Mice were anesthetized using 40 mg/ml Chloral hydrate at 1% volume relative to body mass before the heat treatment. During the heat treatment, a type T thermocouple (0.5 mm diameter) was inserted inside the tissue to monitor the temperature and simultaneously control the ultrasound intensity via an intelligent digital display controller (type XTMC-100; Shanghai Automation Instruments Co. Ltd., Shanghai, China). Usually it took about 2-3 min for the tissues to reach the designated temperature, and then it would remain constant through out the experiment for 30 min.
Infrared thermal imaging
Infrared thermography was taken using a radiometric infrared camera controlled by a real-time image acquisition and processing system provided by Professor Fucheng Sun, Shanghai JiaoTong Univeristy.
Tissue damage evaluation
Tissue damage resulted from ultrasound-mediated hyperthermia treatment was evaluated according to a published method. 25, 26 Briefly, at specific times after heat treatment, 1% Evans Blue Dye (EBD) solution was injected intraperitoneally at 1% volume relative to body mass. At 24 h after injection, mice were killed, and muscles were collected. Slice samples (20 mm) were prepared using a Cryostat (Leica CM1850, Germany) and examined under a fluorescent microscope (Leica DME, Germany). The excitation wavelength was set at 460-490 nm. Fluorescent images were recorded with a SONY digital camera. Raw images were showed without processing.
Data representation and statistical analysis
Unless otherwise stated, experiment groups contained at least six subjects each, and results were shown as mean7s.d. According to our preliminary observation, the absolute values of activated luciferase expression seemed to vary with the age and batch of the mice. So we took an effort to use a relatively homogenous population in each experiment. All the comparative studies were carried out using mice in the same batch with similar age and weight. However, the absolute values from different studies may not be comparable.
We tested the significance of the differences between experimental data groups using the one-tailed Student's 
